Case Studies


Reverse Merger – Investor Credibility & Visibility

National, Clinical, Pre-clinical, Public

A reverse merger into a public shell with a complex, warrant-heavy capital structure created challenges for a clinical-stage company developing transformative gene therapies and biologics. LHS aimed to support Ocugen’s efforts to leverage its transformative technology with investors – including VCs and institutional investors. The goal was maintaining interest and building commitment of existing retail investor shareholder base.

LHS Solution

  • Implemented a comprehensive suite of investor relations services – from strategic counsel to tactical execution and administrative support
  • Communicated extensively to set expectations with existing retail shareholder base through consistent messaging around milestones, operational goals and financial guidance
  • Employed LHS’ extensive capital markets contacts to introduce management to key investors and solicit unbiased investor feedback on company story
  • Developed new investor presentation using LHS Fifteen Slide® Presentation methodology


  • Stabilized stock price volatility, short interest swings and trading volume spikes
  • Developed new communications vehicles to successfully engage with both retail and institutional investors
  • Expanded presence into high profile investor and medical conferences
  • Prominent initial sell-side analyst coverage – Chardan Capital, HC Wainwright
  • Secured top-tier media coverage and developed thought leadership opportunities for senior management